OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 66 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,633,835 | +99.9% | 4,504,764 | +46.2% | 3.24% | +108.1% |
| Q2 2023 | $27,830,460 | +260119.4% | 3,082,000 | 0.0% | 1.56% | +121.4% |
| Q1 2023 | $10,695 | +109.7% | 3,082,000 | +48.0% | 0.70% | +106.5% |
| Q4 2022 | $5,101 | -99.9% | 2,082,000 | 0.0% | 0.34% | -15.2% |
| Q3 2022 | $5,746,000 | -32.2% | 2,082,000 | 0.0% | 0.40% | -37.3% |
| Q2 2022 | $8,474,000 | -4.5% | 2,082,000 | 0.0% | 0.64% | -5.9% |
| Q1 2022 | $8,869,000 | -56.3% | 2,082,000 | -4.0% | 0.68% | -43.6% |
| Q4 2021 | $20,310,000 | -76.0% | 2,169,871 | -29.4% | 1.21% | -64.9% |
| Q3 2021 | $84,705,000 | -1.5% | 3,073,485 | 0.0% | 3.44% | +17.8% |
| Q2 2021 | $85,996,000 | -18.2% | 3,073,485 | -3.8% | 2.92% | +24.8% |
| Q1 2021 | $105,084,000 | -29.1% | 3,195,544 | 0.0% | 2.34% | -33.6% |
| Q4 2020 | $148,169,000 | – | 3,195,544 | – | 3.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $103,181,000 | 7.44% |
| BVF INC/IL | 6,661,503 | $183,591,000 | 7.16% |
| VR Adviser, LLC | 1,536,193 | $42,337,000 | 5.44% |
| Cormorant Asset Management, LP | 3,073,485 | $84,705,000 | 3.44% |
| GREAT POINT PARTNERS LLC | 329,086 | $9,070,000 | 2.11% |
| Vivo Capital, LLC | 1,238,575 | $34,135,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 150,500 | $4,148,000 | 1.46% |
| Foresite Capital Management IV, LLC | 342,030 | $9,426,000 | 1.39% |
| RA Capital Management | 2,150,404 | $59,265,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 338,381 | $9,326,000 | 0.78% |